PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

119 hedge funds and large institutions have $686M invested in Pacific Biosciences in 2015 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 12 closing their positions.

Holders
119
Holders Change
+29
Holders Change %
+32.22%
% of All Funds
3.13%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.11%
New
41
Increased
36
Reduced
29
Closed
12
Calls
$8.36M
Puts
$9.18M
Net Calls
-$813K
Net Calls Change
-$920K

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$47.5M
2
GGHC
2
Gilder Gagnon Howe & Co
New York
$43.1M
3
BM
3
Bridger Management
New York
$28.3M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$20.8M
5
BIM
5
Bogle Investment Management
Massachusetts
$10.1M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$6.17M
2
DM
2
Deerfield Management
New York
$18.2M
3
CCM
3
Consonance Capital Management
New York
$72.2M
4
RCM
4
Raging Capital Management
New Jersey
$0
5
EAM
5
EverPoint Asset Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EDRH
126
Edmond de Rothschild Holding
Switzerland
– -$44K -12,000 Closed
EDRS
127
Edmond de Rothschild (Suisse)
Switzerland
– -$44K -12,000 Closed
TRCT
128
Tower Research Capital (TRC)
New York
– -$43K -11,824 Closed
MC
129
Muhlenkamp & Co
Pennsylvania
– -$41K -11,125 Closed
SGCA
130
Steel Grove Capital Advisors
Tennessee
– -$40K -11,000 Closed
NFG
131
Next Financial Group
Texas
– -$5K -1,500 Closed
2 3 4 5
6